IntrinsiQ to discuss clinical oncology treatment guidelines

IntrinsiQ president Jeff Forringer will discuss clinical oncology treatment guidelines – and what drives variations from the standard-of-care – at the 6th Annual ICORE/Magellan Oncology Summit this Friday in New York.

As the economics of chemotherapy have fundamentally changed within the past five years, Forringer has been tapped to share his insights into today’s clinical cancer care process, and how physicians’ treatment decisions impact healthcare costs nationwide. His presentation will draw from IntrinsiQ’s unmatched insight into the treatment decisions of oncologists nationwide to show how doctors truly practice, the factors that bear the greatest influence on outcomes and costs, and how private practices differ from hospital settings.

The Summit is designed to address participant questions with panels comprised of nationally recognized payors, policy-makers and oncologists, who will address the key issues facing the oncology specialty in 2009 and beyond.

http://www.intrinsiq.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Extracellular vesicles play key role in cancer drug resistance